Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
NeLM news service
AWMSG issues proposed national prescribing indicators for 2010-2011

Source: All Wales Medicines Strategy Group (AWMSG)

Date published: 22/09/2009 14:33

Summary
by: Nicola Pocock

The All Wales Medicines Strategy Group (AWMSG) has published the proposed national prescribing indicators for 2010-2011, covering statins, ACE inhibitors, chiral drugs, hypnotics and anxiolytics, NSAIDs and antibiotics.  Please see the link below for details.

Link

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Related evidence
2.5.5 Drugs affecting the renin-angiotensin system
11/10/2011
Scottish Medicines Consortium accepts Sevikar HCT® (olmesartan medoxomil, amlodipine besilate and hydrochlorothiazide) for use in NHS Scotland
11/10/2011
Scottish Medicines Consortium accepts Sevikar HCT® (olmesartan medoxomil, amlodipine besilate and hydrochlorothiazide) for use in NHS Scotland
11/10/2011
Scottish Medicines Consortium accepts Sevikar HCT® (olmesartan medoxomil, amlodipine besilate and hydrochlorothiazide) for use in NHS Scotland
2.12 Lipid-regulating drugs
02/02/2012
Bezafibrate for primary biliary cirrhosis
19/01/2012
AWMSG issues Final Appraisal Recommendation on rosuvastatin (Crestor®)
11/10/2011
Scottish Medicines Consortium does not recommend rosuvastatin (Crestor®) for use in NHS Scotland for prevention of major cardiovascular events
4.1 Hypnotics and anxiolytics
18/11/2011
Melatonin for non-respiratory sleep disorders in visually impaired children
08/02/2011
New CKS Topic: Delirium
12/10/2010
CKS Topic: Temporomandibular joint disorders
5.1 Antibacterial drugs
09/11/2011
Updated PRODIGY (formerly CKS) topics on gonorrhoea, pelvic inflammatory disease and scrotal swelling
20/10/2011
Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
07/10/2011
Updated PRODIGY (formerly CKS) topic on COPD
10.1.1 Non-steroidal anti-inflammatory drugs
08/11/2011
SMC does not recommend naproxen + esomeprazole combination product (Vimovo®)
08/08/2011
Vimovo (esomeprazole and naproxen) primary care briefing (Aug 2011 update)
01/08/2011
Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants
Related news
2.5.5 Drugs affecting the renin-angiotensin system
12/01/2012
Case control study: Antihypertensive drugs and risk of incident gout among patients with hypertension
10/01/2012
Meta-analysis: The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury
04/01/2012
Direct Healthcare Professional Communication on potential risks of cardiovascular and renal adverse events with aliskiren (Rasilez™)
2.12 Lipid-regulating drugs
03/02/2012
Meta-analysis: Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death
02/02/2012
Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction
02/02/2012
Meta-analysis of statin effects in women versus men
4.1 Hypnotics and anxiolytics
20/01/2012
EMA recommends suspension of marketing authorisations for meprobamate-containing medicines in the EU
20/01/2012
Seminar: Chronic insomnia
23/12/2011
Updated IV monograph on Diazepam emulsion
5.1 Antibacterial drugs
09/02/2012
Department of Health announces funding for new research into antibiotic-resistance bacteria
08/02/2012
RCT: Fidaxomicin versus vancomycin for Clostridium difficile infection
07/02/2012
Review: Management of infective endocarditis - challenges and perspectives
10.1.1 Non-steroidal anti-inflammatory drugs
27/01/2012
MeReC Bulletin: Implementing key therapeutic topics – NSAIDS, antibiotics, and inhaled corticosteroids in asthma
15/12/2011
NSAID use among women and the risk of birth defects: case control study
29/11/2011
MeReC Rapid Review: New evidence for naproxen/esomeprazole combination (Vimovo®) in knee osteoarthritis
Back